Literature DB >> 2342067

Highly active and selective anticoagulants: D-Phe-Pro-Arg-H, a free tripeptide aldehyde prone to spontaneous inactivation, and its stable N-methyl derivative, D-MePhe-Pro-Arg-H.

S Bajusz1, E Szell, D Bagdy, E Barabas, G Horvath, M Dioszegi, Z Fittler, G Szabo, A Juhasz, E Tomori.   

Abstract

D-Phe-Pro-Arg-H sulfate (GYKI-14166) is a highly active and selective inhibitor of thrombin both in vitro and in vivo. Recent studies on the stability of D-Phe-Pro-Arg-H in neutral aqueous solution at higher temperature have revealed that it is transformed into inactive 5,6,8,9,10,10a-hexahydro-2-(3'- guanidinopropyl)-5-benzyl-6-oxo- imidazo[1,2-a]pyrrolo[2,1-c]pyrazine. No such inactivation could be observed with Boc-D-Phe-Pro-Arg-H (GYKI-14451), but this compound was far less specific than the free peptide as it inhibited thrombin and, for instance, plasmin equally well. Assuming that the transformation of free tripeptide aldehyde, mentioned above, can only be initiated by a primary amino terminus, the N-alkyl derivatives of D-Phe-Pro-Arg-H were prepared. Of the new analogues, D-MePhe-Pro-Arg-H (GYKI-14766) proved to be as highly active and selective anticoagulant as its parent compound and was not inactivated by transformation into a heterocyclic compound.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2342067     DOI: 10.1021/jm00168a030

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  7 in total

1.  Structural basis for chemical inhibition of human blood coagulation factor Xa.

Authors:  K Kamata; H Kawamoto; T Honma; T Iwama; S H Kim
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-09       Impact factor: 11.205

2.  A new combination of protecting groups and links for encoded synthetic libraries suited for consecutive tests on the solid phase and in solution.

Authors:  E R Felder; G Heizmann; I T Matthews; H Rink; E Spieser
Journal:  Mol Divers       Date:  1996-02       Impact factor: 2.943

3.  Design, structure-based focusing and in silico screening of combinatorial library of peptidomimetic inhibitors of Dengue virus NS2B-NS3 protease.

Authors:  Vladimir Frecer; Stanislav Miertus
Journal:  J Comput Aided Mol Des       Date:  2010-03-21       Impact factor: 3.686

4.  Molecular basis for the inhibition of human alpha-thrombin by the macrocyclic peptide cyclotheonamide A.

Authors:  B E Maryanoff; X Qiu; K P Padmanabhan; A Tulinsky; H R Almond; P Andrade-Gordon; M N Greco; J A Kauffman; K C Nicolaou; A Liu
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-01       Impact factor: 11.205

5.  Preparations of psi-peptide bond and peptide-aldehyde inhibitors of atrial granule serine proteinase, a candidate processing enzyme of pro-atrial natriuretic factor.

Authors:  A Damodaran; R B Harris
Journal:  J Protein Chem       Date:  1995-08

6.  Comparison of the structures of the cyclotheonamide A complexes of human alpha-thrombin and bovine beta-trypsin.

Authors:  V Ganesh; A Y Lee; J Clardy; A Tulinsky
Journal:  Protein Sci       Date:  1996-05       Impact factor: 6.725

7.  Influence of aromatic and aliphatic moieties on thrombin inhibitors potency.

Authors:  Alexey Poyarkov; Xavier Rocabayera; Svetlana Poyarkova; Valery Kukhar
Journal:  Open Biochem J       Date:  2008-11-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.